Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
AACR 2020: Study finds no overall survival benefit, but improved quality of life with talazoparib in advanced BRCA-mutated breast cancer
Phase III EMBRACA trial survival benefit results may be affected by subsequent treatments New data…
Immune system changes occur early in development of multiple myeloma, study finds
Researchers use single-cell RNA sequencing to map changes in immune microenvironment in myeloma precursor conditions;…
Immune system could be key to reducing the growth of prostate cancer spread to the bone
A new approach to prostate cancer treatment increases the visibility of prostate cancer cells that…
Partial breast irradiation may be as effective as whole breast irradiation in preventing recurrence in patients with early breast cancer
- Adding tucatinib to drug combination extends survival for advanced HER2-positive breast cancer patients
- Breast cancer preventive effects of anastrozole persist long after stopping treatment
- Combining atezolizumab with neoadjuvant chemotherapy does not improve pathologic complete response rates for patients with triple-negative breast cancer
LSD’s medical comeback
By Sam Wong. In a town in Switzerland, people with cancer are taking LSD to help them deal with the…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.